Literature DB >> 20409380

Streptococcus dysgalactiae subsp. equisimilis Bacteremia, Finland, 1995-2004.

Sari Rantala1, Susanna Vahakuopus, Jaana Vuopio-Varkila, Risto Vuento, Jaana Syrjanen.   

Abstract

We conducted a retrospective population-based study of 140 episodes of Streptococcus dysgalactiae subsp. equisimilis bacteremia occurring in Finland during 1995-2004. Rare emm types were associated with more severe disease and increased mortality rates. Skin and soft tissue infections were more frequent clinical signs among cases caused by common emm types.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409380      PMCID: PMC2953979          DOI: 10.3201/eid1605.080803

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Lancefield groups C and G β-hemolytic streptococci (GCS and GGS) may colonize the pharynx, skin, gastrointestinal tract, and female genitourinary tracts (). According to recent taxonomic studies, large colony-forming groups C and G streptococci that infect humans are classified as Streptococcus dysgalactiae subsp. equisimilis (). S. dysgalactiae subsp. equisimilis and S. pyogenes share virulence factors (,). The M protein is an important virulence factor because it confers resistance to phagocytosis (). As with emm genes of S. pyogenes, the emm homologs of groups C and G S. dysgalactiae subsp. equisimilis are used for sequence-based typing (,,), with >50 sequence types currently described (www.cdc.gov/ncidod/ biotech/strep/emmtypes.htm). The aim of our study was to determine the clinical signs, epidemiologic characteristics, and emm types of S. dysgalactiae subsp. equisimilis bacteremia during the 10-year observation period in Finland.

The Study

We retrospectively reviewed the medical records of all adult patients (>16 years of age) in Pirkanmaa Health District, Finland, with >1 blood cultures positive for group C or group G S. dysgalactiae subsp. equisimilis from January 1995 through December 2004. The Pirkanmaa Health District (460,000 inhabitants) has 1 tertiary care hospital (Tampere University Hospital) and 4 other hospitals (Hatanpää City Hospital and the District Hospitals in Valkeakoski, Vammala, and Mänttä). Laboratory records were screened to identify all blood cultures positive for group C or group G S. dysgalactiae subsp. equisimilis during the study period. Our case definition included all patients who had a positive blood culture for S. dysgalactiae subsp. equisimilis and clinical signs compatible with septicemia. A severe disease was defined as a septicemia leading to death or needing intensive care unit treatment. All 128 GGS isolates and 12 of 18 GCS isolates were confirmed to be S. dysgalactiae subsp. equisimilis. Thus, these 140 episodes of S. dysgalactiae subsp. equisimilis septicemia (involving 137 patients) comprised the present study. Two of the isolates (1 GGS and 1 GCS) were not available for emm typing, and 138 of the S. dysgalactiae subsp. equisimilis isolates (from 135 patients) were sequenced to identify the emm gene. Routine blood samples were drawn into aerobic and anaerobic bottles and cultivated by standard methods as reported (). S. dysgalactiae subsp. equisimilis isolates were further analyzed by emm typing. Nontypeable strains and strains isolated from patients with recurrent bacteremia were characterized by using pulsed-field gel electrophoresis (PFGE). The emm typing was performed according to the protocol of the Centers for Disease Control and Prevention (www.cdc.gov/ncidod/biotech/strep/strepblast.htm). If the emm gene could not be amplified with primers 1 and 2, alternative primers MF1/MR1 were used (). PFGE was performed as described (). DNA profiles were analyzed by using Bionumerics software (Applied Maths, Kortrijk, Belgium) and interpreted according to the guidelines described (). Strains with >85% similarity were considered to be related types. SPSS software version 7.5 (SPSS, Chicago, IL, USA) was used for statistical analyses, and a 2-sided p value <0.05 was regarded as the level for significance. Categorical data were analyzed by χ² test or Fisher exact test as appropriate. Nonparametric data were analyzed by using the Mann-Whitney U test. Odds ratios were expressed with 95% confidence intervals. The median age of patients (73 men, 62 women) was 67 years (range 17–90 years). Cardiovascular diseases (41%), diabetes (25%), and malignancies (23%) were the 3 most prominent underlying conditions. We found 18 emm types (including 4 subtypes of stG6: stG6.0, stG6.1, stG6.3, and stG6.4). StG480 (27 isolates), stG6 (23 isolates), and stG485 (22 isolates) were the 3 most common emm types and represented 51% of all isolates (Figure 1). Eight of group G S. dysgalactiae subsp. equisimilis isolates remained nontypeable. PFGE analysis showed 2 strains to be related (>85% similarity). The rest of the nontypeable strains were sporadic (6 isolates).
Figure 1

emm types of 138 Streptococcus dysgalactiae subsp. equisimilis bacteremic isolates obtained during 1995–2004, Finland. NT, nontypeable.

emm types of 138 Streptococcus dysgalactiae subsp. equisimilis bacteremic isolates obtained during 1995–2004, Finland. NT, nontypeable. We divided bacteremia episodes into 2 groups: those caused by the 5 most common emm types and each representing >5% of all episodes (97 episodes, common emm types) and those caused by the less common or nontypable emm types (41 episodes, rare emm types). We could not find an association between emm type and clinical features such as age or underlying disease. Severe disease was caused more often by rare emm types than by common emm types. Mortality rates were higher in patients with bacteremia caused by rare types than that caused by common types (Table 1). Four patients had recurrent S. dysgalactiae subsp. equisimilis bacteremia (Table 2). PFGE profiles showed that strains isolated from the same patient in recurring infections were identical (Figure 2).
Table 1

Disease severity among 138 episodes of Streptococcal dysgalactiae subsp. equisimilis bacteremia, Finland, 1995–2004*

Disease severityNo. (%) common emm types, n = 97No. (%) rare emm types, n = 41Odds ratio (95% CI)p value†
30-day mortality rate11 (11)12 (29)3.2 (1.3–8.1)0.01
Patient admitted to ICU5 (5)6 (15)3.2 (0.9–11)0.084
Patient death or ICU treatment12 (12)15 (37)4.1 (1.7–9.8)0.001
Hypotension‡13 (13)10 (24)2.1 (0.8–5.2)0.113
DIC§2 (2)6 (15)8.1 (1.6–42.3)0.009
Multiorgan failure2 (2)4 (10)5.1 ( 0.9–29.2)0.064
STSS¶2 (2)4 (10)5.1 ( 0.9–29.2)0.064

*CI, confidence interval; ICU, intensive care unit; DIC, disseminated intravascular coagulation; STSS, streptococcal toxic shock syndrome. Patients who had both clinical data and isolates available.
†χ² test or Fisher exact test as appropriate.
‡Hypotensive (BP <90 mm Hg) at least once 0–2 days after positive blood culture.
§Thrombocyte count <100 x 109/L.
¶The definition of STSS was based on a consensus definition, including identification of β-hemolytic streptococci from a normally sterile site, septic shock, and multiorgan failure.

Table 2

Characteristics of recurrent episodes of group G Streptococcal dysgalactiae subsp. equisimilis bacteremia, Finland, 1995–2004*

Patient no.emm type
Time to recurrence, moClinical signsPFGE pattern
Episode 1Episode 2Episode 3
1stG6stG6stG615; 3CellulitisUnique, identical in episodes 1–3
2stG6stG668CellulitisUnique, identical in episodes 1 and 2
3stG480†stG48028SpondylitisUnique, identical in episodes 1 and 2
4stG480NA‡21CellulitisUnique

*PFGE, pulsed-field gel electrophoresis.
†Blood culture taken outside Pirkanmaa Health District, isolate available.
‡Blood culture taken outside Pirkanmaa Health District, no isolate available.

Figure 2

Dendrogram and pulsed-field gel electrophoresis (PFGE) profiles of the strains isolated from patients with recurrent group G Streptococcus dysgalagtiae subsp. equisimilis bacteremia, Finland. Dendogram was generated by using Bionumerics software (Applied Maths, Kortrijk, Belgium) with a 1.0% lane optimization and 1.5% band position tolerance.

*CI, confidence interval; ICU, intensive care unit; DIC, disseminated intravascular coagulation; STSS, streptococcal toxic shock syndrome. Patients who had both clinical data and isolates available.
†χ² test or Fisher exact test as appropriate.
‡Hypotensive (BP <90 mm Hg) at least once 0–2 days after positive blood culture.
§Thrombocyte count <100 x 109/L.
¶The definition of STSS was based on a consensus definition, including identification of β-hemolytic streptococci from a normally sterile site, septic shock, and multiorgan failure. *PFGE, pulsed-field gel electrophoresis.
†Blood culture taken outside Pirkanmaa Health District, isolate available.
‡Blood culture taken outside Pirkanmaa Health District, no isolate available. Dendrogram and pulsed-field gel electrophoresis (PFGE) profiles of the strains isolated from patients with recurrent group G Streptococcus dysgalagtiae subsp. equisimilis bacteremia, Finland. Dendogram was generated by using Bionumerics software (Applied Maths, Kortrijk, Belgium) with a 1.0% lane optimization and 1.5% band position tolerance. Common emm types were more frequently manifested as skin and soft tissue infections than were rare emm types, 75% vs. 54%, respectively (p = 0.012). The most frequent source of bacteremia was cellulitis (51%). We also found an association between a common emm type and cellulitis. Cellulitis was a more frequent clinical sign among patients with infections caused by common emm types than by rare emm types (p = 0.007); 64% of patients infected by common emm types had cellulitis as an initial clinical manifestation versus 39% of patients infected by rare emm types.

Conclusions

Our study showed that mortality rates were higher in patients with S. dysgalactiae subsp. equisimilis bacteremia caused by rare emm types than in those with bacteremia caused by common emm types. The reason for this finding is unclear. One explanation for this might be that patients contract certain prevailing bacterial strains (so-called common types) more often, and a prior antigen challenge and subsequent humoral response may play a role. Severe disease (death or intensive care unit treatment) was also caused more often by rare emm types than by common emm types. We found also an association between a common emm type and cellulitis as a clinical manifestation; the common emm types were also associated with skin and soft tissue infections. In our comprehensive study with molecular typing data for 138 invasive S. dysgalactiae subsp. equisimilis isolates from human infections, we found 18 emm types, which is consistent with previous reports by Cohen-Poradosu et al. () and Broyles et al. () . These 2 studies reported stG485.0. or StG6, StG245, and StG2078 as the most common emm types, respectively. Thus, emm typing provides a useful tool for comparative epidemiologic analysis of GGS isolates from various geographic regions. Our results also suggest that certain emm types may prevail among bacteria that cause human infections. Our study did not show any obvious time shifts in the occurrence of certain emm types. A noteworthy finding in our series was the high frequency of recurrent group G S. dysgalactiae subsp. equisimilis bacteremia as reported earlier (,). Clinicians should be alert to this phenomenon, which seems to be more common than recurrent group A streptococcal bacteremia. The dynamics of interspecies transfer of virulence loci between group A streptococci, GGS, and GCS (), as well as potential genetic transfer or intragenomic events causing interconversion of group antigen types, remains to be resolved. Further characterization of the strains by multilocus sequence typing would be of interest (). We conclude that severity of disease and mortality rates were higher in persons with S. dysgalactiae subsp. equisimilis bacteremia caused by rare emm types than that caused by common emm types. Skin and soft tissue infections such as cellulitis were significantly more frequent clinical signs among episodes caused by common emm types.
  15 in total

1.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

2.  M proteins of group G streptococci isolated from bacteremic human infections.

Authors:  A L Bisno; D E Craven; W R McCabe
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  M proteins of group C streptococci isolated from patients with acute pharyngitis.

Authors:  A L Bisno; C M Collins; J C Turner
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  emm typing of invasive T28 group A streptococci, 1995-2004, Finland.

Authors:  Tuula Siljander; Maija Toropainen; Anna Muotiala; Nancy P Hoe; James M Musser; Jaana Vuopio-Varkila
Journal:  J Med Microbiol       Date:  2006-12       Impact factor: 2.472

Review 6.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

7.  Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings.

Authors:  Tuula Siljander; Matti Karppelin; Susanna Vähäkuopus; Jaana Syrjänen; Maija Toropainen; Juha Kere; Risto Vuento; Tapio Jussila; Jaana Vuopio-Varkila
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

8.  Group G streptococcal bacteremia in Jerusalem.

Authors:  Ronit Cohen-Poradosu; Joseph Jaffe; David Lavi; Sigal Grisariu-Greenzaid; Ran Nir-Paz; Lea Valinsky; Mary Dan-Goor; Colin Block; Bernard Beall; Allon E Moses
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

9.  emm typing and validation of provisional M types for group A streptococci.

Authors:  R Facklam; B Beall; A Efstratiou; V Fischetti; D Johnson; E Kaplan; P Kriz; M Lovgren; D Martin; B Schwartz; A Totolian; D Bessen; S Hollingshead; F Rubin; J Scott; G Tyrrell
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

10.  Bacteremia caused by group G Streptococci, taiwan.

Authors:  Chun-Hsing Liao; Liang-Chun Liu; Yu-Tsung Huang; Lee-Jeng Teng; Po-Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more
  10 in total

Review 1.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

2.  Distribution of emm types in invasive and non-invasive group A and G streptococci.

Authors:  S Vähäkuopus; R Vuento; T Siljander; J Syrjänen; J Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-16       Impact factor: 3.267

3.  Genotypic characterization of toxigenic group C and G streptococci isolated in Chennai, South India.

Authors:  D Prabu; Thangam Menon
Journal:  Folia Microbiol (Praha)       Date:  2011-06-28       Impact factor: 2.099

4.  Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features.

Authors:  Anna Bläckberg; Bo Nilson; Volkan Özenci; Lars Olaison; Magnus Rasmussen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-08       Impact factor: 3.267

5.  Recurrent SDSE bacteraemia resulting in streptococcal toxic shock syndrome in a patient with Noonan syndrome.

Authors:  Kei Suzuki; Akiko Nakamura; Ken Ishikura; Hiroshi Imai
Journal:  BMJ Case Rep       Date:  2016-08-02

6.  Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010.

Authors:  Julien Loubinoux; Céline Plainvert; Gislène Collobert; Gérald Touak; Anne Bouvet; Claire Poyart
Journal:  J Clin Microbiol       Date:  2013-05-22       Impact factor: 5.948

7.  Potential Factors Enabling Human Body Colonization by Animal Streptococcus dysgalactiae subsp. equisimilis Strains.

Authors:  Marcin Ciszewski; Eligia M Szewczyk
Journal:  Curr Microbiol       Date:  2017-03-18       Impact factor: 2.188

8.  Emergence of a Streptococcus dysgalactiae subspecies equisimilis stG62647-lineage associated with severe clinical manifestations.

Authors:  Oddvar Oppegaard; Haima Mylvaganam; Steinar Skrede; Paul Christoffer Lindemann; Bård Reiakvam Kittang
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

9.  Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections.

Authors:  Yoshihiro Fujiya; Kayoko Hayakawa; Yoshiaki Gu; Kei Yamamoto; Momoko Mawatari; Satoshi Kutsuna; Nozomi Takeshita; Yasuyuki Kato; Shuzo Kanagawa; Norio Ohmagari
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

10.  Streptococcus dysgalactiae subsp. equisimilis Isolated From Infections in Dogs and Humans: Are Current Subspecies Identification Criteria accurate?

Authors:  Marcin Ciszewski; Kamil Zegarski; Eligia M Szewczyk
Journal:  Curr Microbiol       Date:  2016-08-09       Impact factor: 2.188

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.